EUVIMEDEUVIMED entdecken
Crossref

Vortioxetine transiently alters basal locomotor activity but does not produce sedation in rats

Susana Barbosa-Méndez, Alberto Salazar-Juárez

Physiology & Behavior · 2026-10 · 315 · 115412

DOI: 10.1016/j.physbeh.2026.115412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiology & Behavior, 2026-10. Verfasst von Susana Barbosa-Méndez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Behavioral Pharmacology, Microsurgery and Experimental Therapeutics, National Institute of Psychiatry, Ramón de la Fuente Muñiz, México. Hauptthemen laut MEDLINE: Piperazines, Motor Activity, Sulfides, Antidepressive Agents. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sedation is a major side effect of many pharmacotherapies for depression, negatively affecting treatment compliance, particularly in long-term treatment. Vortioxetine, a recently approved antidepressant for major depressive disorder, has been reported in clinical studies to be safe and well-tolerated, without causing sedation. However, recent reports have indicated that vortioxetine may, in fact, cause daytime sedation. Therefore, this study aimed to explore the effects of acute and chronic administration of varying doses of vortioxetine on sedation in rats. Sedation was assessed behaviorally using the rota-rod, spontaneous locomotor activity, and fixed-bar tests. In addition to behavioral assessments, the sedation rating scale was used, and body weight was monitored to indicate metabolic effects of different vortioxetine doses (5, 10, and 20 mg/kg). Our results showed that, compared to trazodone, acute and chronic dosing of vortioxetine produced a transient reduction in spontaneous locomotor activity. Furthermore, the fixed-bar, rota-rod, and sedation ratings were not significantly altered by any dose of vortioxetine. These results suggest that vortioxetine, at the tested doses, is safe, well-tolerated, and does not produce significant sedative effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperazinesMotor ActivitySulfidesAntidepressive AgentsHypnotics and SedativesAnimalsVortioxetineMaleDose-Response Relationship, DrugRatsRats, Sprague-DawleyBody Weight

Stichwörter der Autor:innen

AntidepressantDepressionDosing schedulesPharmacotherapySedationVortioxetine

Substanzen

VortioxetinePiperazinesSulfidesAntidepressive AgentsHypnotics and Sedatives

Autor:innen und Institutionen

  • Behavioral Pharmacology, Microsurgery and Experimental Therapeutics, National Institute of Psychiatry, Ramón de la Fuente Muñiz, México.
  • Behavioral Pharmacology, Microsurgery and Experimental Therapeutics, National Institute of Psychiatry, Ramón de la Fuente Muñiz, México. Electronic address: azazel_vamp@yahoo.com.mx.

Förderung

  • Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz

Zitieren

APA

Barbosa-Méndez, S., & Salazar-Juárez, A. (2026). Vortioxetine transiently alters basal locomotor activity but does not produce sedation in rats. Physiology & Behavior, 315, 115412. https://doi.org/10.1016/j.physbeh.2026.115412

Vancouver

Barbosa-Méndez S, Salazar-Juárez A. Vortioxetine transiently alters basal locomotor activity but does not produce sedation in rats. Physiology & Behavior. 2026;315:115412. doi:10.1016/j.physbeh.2026.115412

BibTeX
@article{BarbosaMndez2026,
  author = {Barbosa-Méndez, Susana and Salazar-Juárez, Alberto},
  title = {Vortioxetine transiently alters basal locomotor activity but does not produce sedation in rats},
  journal = {Physiology & Behavior},
  year = {2026},
  volume = {315},
  pages = {115412},
  doi = {10.1016/j.physbeh.2026.115412}
}
Kostenlos starten →